4.0 Read 205 reviews
Overview
What you will study
Many recent initiatives have designed care models that incorporate pharmacists into the initiation, titration and monitoring of drug therapy. In The Management of Cardiovascular and Kidney Disease course offered by Harvard University , we will describe current approaches to pharmacist and physician collaborative practices and their effect on care optimization using a cardiovascular-renal-metabolic collaborative clinic as an example.
Programme Structure
The program focuses on:
- Appraise the benefits and risks of SGLT2 inhibitors
- The benefits and risks of GLP-1 receptor agonists
- People with type 2 diabetes mellitus, heart failure and chronic kidney disease
- Formulate a comprehensive pharmacotherapeutic plan to reduce cardiovascular and kidney risk in people with type 2 diabetes mellitus, heart failure and chronic kidney disease
- Describe models for the co-management of people with increased cardiovascular and kidney risk by physicians and pharmacists
Key information
Duration
- Part-time
- 1 days
Start dates & application deadlines
You can apply for and start this programme anytime.
More details
- On Demand
Language
English
Delivered
Online
Disciplines
Health Administration Health Sciences View 62 other Short Courses in Health Administration in United StatesAcademic requirements
We are not aware of any specific GRE, GMAT or GPA grading score requirements for this programme.
English requirements
We are not aware of any English requirements for this programme.
Other requirements
General requirements
- Pharmacists
- Pharmacy Residents
- Physicians
- Physician Assistants
- Clinicians
- Medical Residents
- Nurses and Nurse Practitioners
Tuition Fee
To always see correct tuition fees
-
International
45 USD/yearTuition FeeBased on the tuition of 45 USD per year during 1 days. -
National
45 USD/yearTuition FeeBased on the tuition of 45 USD per year during 1 days.
Funding
Improve page content